Press Releases

 
Press Releases
  Date Title View
Sep 2, 2015
LYON, France, Sept. 2, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski, Chief Executive Officer of EDAP TMS is scheduled to present at the 17th Annual Rodman & Renshaw Global Investment conference being held September 8-10, 2015 in New York, NY. Details o...
Aug 26, 2015
Second quarter 2015 revenue increased 39% year-over-year to EUR 7.8 million (USD 8.7 million) Second Quarter 2015 HIFU revenues increased 55% year-over-year Strong and increased cash position at €11.8 Million on June 30, 2015. Formal complete response to recent FDA Letter submitted on Friday, August 21, 2015 ...
Aug 25, 2015
LYON, France, Aug. 25, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that on Friday August 21, 2015, it submitted a complete, formal response to the U.S. Food and Drug Administration ("FDA") "Deficiency List" (as such communications about a regulatory filing are officially termed). ...
Aug 19, 2015
LYON, France, Aug. 19, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the second quarter ended June 30, 2015 on Wednesday, August 26, 2015, after the close of trading. Company management will host a conference call on Thursday, A...
Jul 21, 2015
LYON, France, July 21, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it has received a letter from the U.S. Food and Drug Administration ("FDA") related to its Direct De Novo 510(k) petition for Ablatherm HIFU in the United States. The "Deficiency List" (as such communications ...
Jul 14, 2015
LYON, France, July 14, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that François Dietsch, currently Group Financial Control Manager and Finance Manager of the Company's French subsidiary, has been promoted to the position of Chief Financial Officer, effective immediately. ...
Jul 7, 2015
LYON, France, July 7, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the adoption of its Focal One system under a pay-per-procedure sale contract by two major University hospitals in Switzerland: the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne and Geneva University Ho...
Jul 2, 2015
LYON, France, July 2, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Eric Soyer, Chief Financial Officer, has resigned from the Company to accept a top management position at a publicly traded biotechnology company. To ensure a smooth transition, Mr. Soyer will remain with the C...
Jun 9, 2015
LYON, France, June 9, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the installation of a Focal One system under a Revenue-per-procedure ("RPP") contract with the Martini-Klinik at the University Hospital Hamburg-Eppendorf (UKE) in Germany. The Martini-Klinik is the world's ...
May 12, 2015
1Q 2015 and Recent Operational Highlights Direct De Novo petition for Ablatherm HIFU submitted to the FDA in April 2015; Treatment-driven revenue from the HIFU division increased 17% year-over-year; Revenue for first quarter 2015 totaled EUR 6.2 million (USD 6.9 million); Canadian regulatory approval of F...
1
... NextLast
= add release to Briefcase